ÈËÆÞÖгöÊÓƵ

Skip to main content
Matthew T. Sweney

Matthew T. Sweney, MD, MS

Languages spoken: English

Clinical Locations

Primary Children's Hospital Outpatient ÈËÆÞÖгöÊÓƵ at Riverton

Riverton
801-213-3599
  • Dr. Sweney is a pediatric neurologist and epileptologist who focuses on the diagnosis and treatment of drug-resistant pediatric epilepsy. He is Medical Director of the Comprehensive Pediatric Epilepsy Program at Primary Children’s Hospital and Program Director of the Pediatric Epilepsy Fellowship at the ÈËÆÞÖгöÊÓƵ of Utah. He is board certified in General Pediatrics, Neurology, Epilepsy, and Clinical Neurophysiology. He participates in all aspects of pediatric epilepsy care, including medication management, non-medication alternatives such as ketogenic diet and neuromodulation, as well as palliative and curative epilepsy surgery. He remains active in ongoing studies into new potential anti-seizure medications and is committed to providing advanced epilepsy care to ÈËÆÞÖгöÊÓƵren of the intermountain region.

    Board Certification

    American Board of Clinical Neurophysiology (Epilepsy Monitoring)
    American Board of Clinical Neurophysiology (Neurophysiologic Intraoperative Monitoring)
    American Board of Pediatrics (Pediatrics)
    American Board of Psychiatry & Neurology (Special Qualification in Child Neurology)
    American Board of Psychiatry & Neurology (Sub: Epilepsy)
  • Dr. Sweney is a pediatric neurologist and epileptologist who focuses on the diagnosis and treatment of drug-resistant pediatric epilepsy. He is Medical Director of the Comprehensive Pediatric Epilepsy Program at Primary Children’s Hospital and Program Director of the Pediatric Epilepsy Fellowship at the ÈËÆÞÖгöÊÓƵ of Utah. He is board certified in General Pediatrics, Neurology, Epilepsy, and Clinical Neurophysiology. He participates in all aspects of pediatric epilepsy care, including medication management, non-medication alternatives such as ketogenic diet and neuromodulation, as well as palliative and curative epilepsy surgery. He remains active in ongoing studies into new potential anti-seizure medications and is committed to providing advanced epilepsy care to ÈËÆÞÖгöÊÓƵren of the intermountain region.

    Board Certification and Academic Information

    Academic Departments Pediatrics -Primary
    Neurology -Primary
    Academic Divisions Neurology
    Board Certification
    American Board of Clinical Neurophysiology (Epilepsy Monitoring)
    American Board of Clinical Neurophysiology (Neurophysiologic Intraoperative Monitoring)
    American Board of Pediatrics (Pediatrics)
    American Board of Psychiatry & Neurology (Special Qualification in Child Neurology)
    American Board of Psychiatry & Neurology (Sub: Epilepsy)

    Education history

    Fellowship Clinical Neurophysiology/Epilepsy - ÈËÆÞÖгöÊÓƵ of Utah Fellow
    General Child Neurology - ÈËÆÞÖгöÊÓƵ of Utah Fellow
    Research Fellow Alternating Hemiplegia of Childhood - ÈËÆÞÖгöÊÓƵ of Utah Research Fellow
    Pediatrics - ÈËÆÞÖгöÊÓƵ of Nebraska - Omaha Resident
    Internship Pediatrics - ÈËÆÞÖгöÊÓƵ of Nebraska - Omaha Intern
    Medicine - ÈËÆÞÖгöÊÓƵ of Nebraska - Omaha M.D.
    Graduate Training Biomedical Engineering - ÈËÆÞÖгöÊÓƵ of Minnesota M.S.
    Bioengineering - ÈËÆÞÖгöÊÓƵ of Nebraska - Lincoln B.S.

    Selected Publications

    Journal Article

    1. Lado FA, Ahrens SM, Riker E, Muh CR, Richardson RM, Gray J, Small B, Lewis SZ, Schofield TJ, Clarke DF, Hopp JL, Lee RR, Salpekar JA, Arnold ST, National Association of Epilepsy Guidelines for Specialized Epilepsy Centers Panel (2024). Guidelines for Specialized Epilepsy Centers: Executive Summary of the Report of the National Association of Epilepsy Centers Guideline Panel. Neurology, 102(4), e208087. ()
    2. McKnight D, Morales A, Hatchell KE, Bristow SL, Bonkowsky JL, Perry MS, Berg AT, Borlot F, Esplin ED, Moretz C, Angione K, Ros-Pohl L, Nussbaum RL, Aradhya S, ELEVIATE Consortium, Haldeman-Englert CR, Levy RJ, Parachuri VG, Lay-Son G, de Montellano DJD, Ramirez-Garcia MA, Bentez Alonso EO, Ziobro J, Chirita-Emandi A, Felix TM, Kulasa-Luke D, Megarbane A, Karkare S, Chagnon SL, Humberson JB, Assaf MJ, Silva S, Zarroli K, Boyarchuk O, Nelson GR, Palmquist R, Hammond KC, Hwang ST, Boutlier SB, Nolan M, Batley KY, Chavda D, Reyes-Silva CA, Miroshnikov O, Zuccarelli B, Amlie-Wolf L, Wheless JW, Seinfeld S, Kanhangad M, Freeman JL, Monroy-Santoyo S, Rodriguez-Vazquez N, Ryan MM, Machie M, Guerra P, Hassan MJ, Candee MS, Bupp CP, Park KL, Muller E 2nd, Lupo P, Pedersen RC, Arain AM, Murphy A, Schatz K, Mu W, Kalika PM, Plaza L, Kellogg MA, Lora EG, Carson RP, Svystilnyk V, Venegas V, Luke RR, Jiang H, Stetsenko T, Dueas-Roque MM, Trasmonte J, Burke RJ, Hurst ACE, Smith DM, Massingham LJ, Pisani L, Costin CE, Ostrander B, Filloux FM, Ananth AL, Mohamed IS, Nechai A, Dao JM, Fahey MC, Aliu E, Falchek S, Press CA, Treat L, Eschbach K, Starks A, Kammeyer R, Bear JJ, Jacobson M, Chernuha V, Meibos B, Wong K, Sweney MT, Espinoza AC, Van Orman CB, Weinstock A, Kumar A, Soler-Alfonso C, Nolan DA, Raza M, Rojas Carrion MD, Chari G, Marsh ED, Shiloh-Malawsky Y, Parikh S, Gonzalez-Giraldo E, Fulton S, Sogawa Y, Burns K, Malets M, Montiel Blanco JD, Habela CW, Wilson CA, Guzmn GG, Pavliuk M (2022). Genetic Testing to Inform Epilepsy Treatment Management From an International Study of Clinical Practice. JAMA Neurol, 79(12), 1267-1276. ()
    3. Baker M, Olsen JC, Wilkes J, Sweney M, Soisson S, Bonkowsky JL (2022). Similar antiseizure medication refill characteristics in Hispanic and White pediatric patients. Epilepsy Res, 184, 106970. ()
    4. Hunsaker JC, Scoville JP, Joyce E, Harper J, Kurudza E, Sweney M, Bollo RJ, Rolston JD (2022). Stereotactic electroencephalography is associated with reduced opioid and nonsteroidal anti-inflammatory drug use when compared with subdural grids: a pediatric case series. J Clin Neurosci, 101, 180-185. ()
    5. Baker M, Mason CC, Wilkes J, Sant D, Sweney M, Bonkowsky JL (2022). Long-Term ÈËÆÞÖгöÊÓƵ Outcomes of Infantile Spasms Following Prednisolone vs. Adrenocorticotropic Hormone Treatment Characterized Using Phenome-Wide Association Study. Front Neurol, 13, 878294. ()
    6. Gregerson CHY, Bakian AV, Wilkes J, Knighton AJ, Nkoy F, Sweney M, Filloux FM, Bonkowsky JL (2019). Disparities in Pediatric Epilepsy Remission Are Associated With Race and Ethnicity. J Child Neurol, 34(14), 928-936. ()
    7. Afra P, Bruggers CS, Sweney M, Fagatele L, Alavi F, Greenwald M, Huntsman M, Nguyen K, Jones JK, Shantz D, Bulaj G (2018). Mobile Software as a Medical Device (SaMD) for the Treatment of Epilepsy: Development of Digital Therapeutics Comprising Behavioral and Music-Based Interventions for Neurological Disorders. Front Hum Neurosci, 12, 171. ()

    Other

    1. Viollet L, Glusman G, Murphy KJ, Newcomb TM, Reyna SP, Sweney M, Nelson B, Andermann F, Andermann E, Acsadi G, Barbano RL, Brown C, Brunkow ME, Chugani HT, Cheyette SR, Collins A, DeBrosse SD, Galas D, Friedman J, Hood L, Huff C, Jorde LB, King MD, LaSalle B, Leventer RJ, Lewelt AJ, Massart MB, Mrida MR 2nd, Ptek LJ, Roach JC, Rust RS, Renault F, Sanger TD, Sotero de Menezes MA, Tennyson R, Uldall P, Zhang Y, Zupanc M, Xin W, Silver K, Swoboda KJ (2015). Correction: Alternating Hemiplegia of Childhood: Retrospective Genetic Study and Genotype-Phenotype Correlations in 187 Subjects from the US AHCF Registry. PLoS One (10(8), pp. e0137370). United States. ()